Vaxcyte, Inc.
Clinical trials sponsored by Vaxcyte, Inc., explained in plain language.
-
New vaccine aims to boost protection against pneumonia in older adults
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new vaccine called VAX-31 to see if it is safe and how well it boosts the immune system against pneumonia bacteria in healthy adults aged 50 and older. All participants have already received a standard pneumonia vaccine at least a year ago. Researchers wil…
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 04, 2026 07:50 UTC
-
Major trial tests Next-Gen pneumonia shot for seniors
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new vaccine called VAX-31 that aims to protect against more strains of bacteria that cause pneumonia and other serious infections. It will enroll 4,000 healthy adults aged 50 and older to compare the safety and immune response of VAX-31 against two existin…
Phase: PHASE3 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:15 UTC